News | December 30, 2025
Cupid to set up FMCG manufacturing facility in Saudi Arabia
The plant is expected to enhance regional supply capabilities
The plant is expected to enhance regional supply capabilities
The study met its primary endpoint with flying colors
The partnership also sets the stage for broader collaboration on rare disease treatments
Lucid-MS represents a potential breakthrough in the treatment of multiple sclerosis
The approval follows results from the DESTINY-Breast06 phase 3 trial, which showed ENHERTU significantly extended progression-free survival compared to chemotherapy
Singlera and Pure Medical will team up with local universities, hospital networks, and national healthcare systems across Western Europe for research studies
The cancellation underscores the regulator’s strict stance against misleading cosmetic claims
The primary goal of the collaboration is joint research into trending and next-generation molecules
The approval makes AQVESME the only FDA-approved therapy for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia
The opening of our 1000th pharmacy in Karnataka marks an important step
Subscribe To Our Newsletter & Stay Updated
